Kern Family donated $100 million to Mayo Clinic to transform health care
On Oct. 23, 2013, the Mayo Clinic announced that Robert and Patricia Kern have given $100 million to…
-
-
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
-
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
-
Biotechnology | COVID-19 | Diagnostics | Disease | Genomics | Therapeutics
The Human Genome Project was completed
On Apr. 13, 2003, the International Human Genome Sequencing Consortium announced the completion of the Human Genome Project…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
Genentech drug Kadcyla (ado-trastuzumab emtansine) was approved
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had licensed ado-trastuzumab emtansine (Kadcyla)…
-
The OHSU/OSU Collaborative Life Sciences Building and Skourtes Tower ‘Topped Out’
On Jan. 17, 2013, E Dunn Construction announced it had topped out the OHSU/OUS Collaborative Life Sciences Building…
-
Sanford Health acquired Hematech
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
-
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders merged three of the four subcategories of possible autistic disorder
In 2013, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders merged three of the…
-
GDF-11 was discovered to reverse cardiac hypertrophy
In 2013, Harvard Medical School researchers announced they had discovered that GDF-11 reverses cardiac hypertrophy, or thickening of…
-
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
-
A new phlebovirus (Heartland virus) associated with severe febrile illness in Missouri published
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
-
The FDA’s “Breakthrough Therapy Designation” was created
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
-
Biotechnology | Disease | FDA | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
-
The U.S. Senate declared May 16 as Hereditary Angioedema Awareness Day (HAE)
On May 16, 2012, the U.S. Senate unanimously passed a resolution (S. Res. 286) recognizing May 16, 2012,…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approved orphan drug Elelyso to treat a form of Gaucher disease
On May 1, 2012, Pfizer and Protalix BioTherapeutics announced that the U.S. Food and Drug Administration (FDA) had approved…
-
Hologic acquired Gen-Probe for $3.7 billion
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
-
University of Washington Medical Center becomes first in PNW to discharge Total Artificial Heart patient
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
Draft sequence of the gorilla genome was published
On Mar. 7, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…
-
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
-
Biotechnology | Disease | FDA | Therapeutics
The FDA approved Korlym for patients with endogenous Cushing’s syndrome
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
-
Middle East Respiratory Syndrome (MERS) was first reported in Saudi Arabia
In 2012, Middle East Respiratory Syndrome (MERS), a viral respiratory illness, was first reported in Saudi Arabia in…
-
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
-
Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…
-
Mayo Clinic announced plans to open a medical school in Scottsdale, Arizona
On Sept. 27, 2011, the Mayo Clinic announced a $120 million plan to open its first medical school…
-
The Monroe Cancer Center opened
On Sept. 2, 2011, the Monroe Cancer Center opened as a joint venture between Karmanos Cancer Institute, Mercy…
-
Disease | FDA | Oncology | Therapeutics
The FDA approved Seattle Genetics’ Adcetris (brentuximab vedotin)
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
-
Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks
On Aug. 17, 2011, researchers at the Stanford University School of Medicine announced they had paired up medicines…
-
Disease | Life Science History | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center performed its 5,000th bone marrow transplant
On Aug. 9, 2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…
-
The Maine Institute for Human Genetics and Health discontinued operations
On Jul. 17, 2011, the Maine Institute for Human Genetics and Health announced that it would cease operations…
